ERNA vs PG
Eterna Therapeutics Inc (ERNA) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the ERNA and PG stock pages for the full models.
Not investment advice.